Breaking Nagasaki Marks 81st Anniversary of Atomic Bombing Amid Shifting Defense Policies Myanmar Military Government Rejects ASEAN Call for Aung San Suu Kyi’s Release Wildfire Engulfs Part of Mount Bromo National Park Cyprus Poised to Become New Natural Gas Supplier to Europe by 2028 Dodgers Snap Losing Streak But Offensive Woes Persist

Sunday August 9, 2026

Reporter

UroGen Pharma Ltd.

3Articles Published

5Communities Covered

Published Articles

Press Release

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Jul 15

Press Release

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Jul 15

Press Release

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Jul 8